<DOC>
	<DOCNO>NCT01118910</DOCNO>
	<brief_summary>The purpose study determine people moist , red , patch skin body fold would benefit treatment area FDA-approved drug call Vusion .</brief_summary>
	<brief_title>Open-Label Pilot Study Efficacy Safety Vusion Ointment Treatment Intertrigo</brief_title>
	<detailed_description>Intertrigo inflammatory condition skin fold , induce aggravate heat , moisture , maceration , friction , lack air circulation . It typically chronic insidious onset itching , burning , sting within affected skin fold . Intertrigo frequently worsen colonized infection , commonly candidal also may bacterial , fungal , viral . The etiology diaper dermatitis show significant overlap intertrigo . Vusion ointment , highly effective treatment diaper dermatitis , use physician treatment intertrigo ; however , paucity data literature regard use Vusion ointment indication . This study first formally investigate efficacy safety Vusion ointment treatment intertrigo .</detailed_description>
	<mesh_term>Intertrigo</mesh_term>
	<criteria>Evidence intertrigo Pregnancy Use systemic topical antifungal corticosteroid treatment previous 14 day 3month treatment period allergy sensitivity Vusion undergo warfarin anticoagulation alcohol drug abuse Investigator determine particpate history noncompliance poor cooperation participation investigaitonal drug study within 30 day Baseline Visit</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>August 2011</verification_date>
	<keyword>Intertrigo</keyword>
	<keyword>Vusion</keyword>
</DOC>